Antares Pharma - 24 Year Stock Price History | ATRS

Historical daily share price chart and data for Antares Pharma since 1996 adjusted for splits. The latest closing stock price for Antares Pharma as of April 03, 2020 is 2.02.
  • The all-time high Antares Pharma stock closing price was 29.40 on January 23, 1997.
  • The Antares Pharma 52-week high stock price is 5.13, which is 154% above the current share price.
  • The Antares Pharma 52-week low stock price is 1.60, which is 20.8% below the current share price.
  • The average Antares Pharma stock price for the last 52 weeks is 3.42.
Antares Pharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 3.3394 4.2600 4.5400 1.7500 2.0200 -57.02%
2019 3.3832 2.8400 5.0600 2.6900 4.7000 72.79%
2018 2.7835 2.0700 3.8000 1.9300 2.7200 36.68%
2017 2.6263 2.3100 3.9600 1.6300 1.9900 -14.59%
2016 1.2668 1.1900 2.3800 0.7057 2.3300 92.56%
2015 2.0714 2.5900 2.9700 1.2100 1.2100 -52.92%
2014 2.9506 4.5400 4.9500 1.8300 2.5700 -42.52%
2013 4.0150 3.8900 4.6900 3.3600 4.4710 17.35%
2012 3.4915 2.1700 5.3200 2.0500 3.8100 73.18%
2011 2.0198 1.7300 2.8200 1.5100 2.2000 29.41%
2010 1.5035 1.1700 1.9500 1.1100 1.7000 49.12%
2009 0.7718 0.4100 1.2700 0.3600 1.1400 208.11%
2008 0.7515 0.9600 1.0800 0.3200 0.3700 -62.24%
2007 1.3969 1.2000 2.1200 0.9500 0.9800 -18.33%
2006 1.2923 1.5400 1.8000 0.8800 1.2000 -22.58%
2005 1.0737 1.4000 1.5500 0.7100 1.5500 14.81%
2004 1.1696 1.0600 1.7000 0.6200 1.3500 31.07%
2003 1.1276 0.3900 3.2500 0.3500 1.0300 145.24%
2002 2.6858 3.7000 4.9800 0.3300 0.4200 -88.65%
2001 3.4770 4.3400 5.0000 2.0000 3.7000 -14.75%
2000 4.2939 1.5600 6.2500 1.5000 4.3400 189.33%
1999 2.6323 2.5000 6.3750 1.2800 1.5000 -21.05%
1998 6.8121 10.0000 13.7500 1.7000 1.9000 -81.00%
1997 17.9822 18.7500 29.4000 9.4000 10.0000 -44.90%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.334B $0.124B
Antares Pharma, Inc. develops, commercializes and markets novel delivery solutions, including needle-free and mini-needle injector systems, gel technologies and transdermal products, which improve both the efficiency of drug therapies and the quality of life for patients. The Company currently distributes its needle-free injector systems for the delivery of insulin and growth hormone in over 20 countries and an estradiol transdermal patch for hormone replacement therapy.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $61.483B 19.50
McKesson (MCK) United States $22.203B 8.71
AmerisourceBergen (ABC) United States $16.747B 11.23
Cooper (COO) United States $14.915B 23.00
Cardinal Health (CAH) United States $13.600B 8.49
Align Technology (ALGN) United States $12.144B 31.09
West Pharmaceutical Services (WST) United States $11.176B 46.71
Laboratory Of America Holdings (LH) United States $11.025B 10.02
Straumann Holding AG (SAUHF) Switzerland $10.733B 0.00
DENTSPLY SIRONA (XRAY) United States $7.850B 14.47
Henry Schein (HSIC) United States $6.646B 13.20
Merit Medical Systems (MMSI) United States $1.679B 20.69
SmileDirectClub (SDC) United States $1.491B 0.00
CONMED (CNMD) United States $1.437B 19.03
STAAR Surgical (STAA) United States $1.311B 60.73
Patterson (PDCO) United States $1.291B 8.98
Atrion (ATRI) United States $1.220B 33.35
Invacare (IVC) United States $0.200B 0.00
Lifevantage (LFVN) United States $0.153B 12.90
Pro-Dex (PDEX) United States $0.059B 15.95
Endologix (ELGX) United States $0.012B 0.00
Biolase (BIOL) United States $0.007B 0.00